Jessica Ortis
General Practice · Baldwin, MDNPI 1053797464
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.5% of the total across 93 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 38 manufacturers, the largest accounting for just 10.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,034 and has fallen 95.7% since, to $45 in 2025. Among general practice clinicians in MD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 93 payments — averaging $23.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$219
- AstraZeneca$188
- Pharmacyclics LLC, An Abbvie Company$158
- Johnson & Johnson$157
- Takeda Pharmaceuticals U.S.A., Inc.$150
- Seagen Inc.$135
- plus $1K from 32 others
What the payments were for
- Food & beverage$2,05696%
- Education$964%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 5 | $219 |
| AstraZeneca(2 entities) | 10 | $188 |
| Pharmacyclics LLC, An Abbvie Company | 7 | $158 |
| Johnson & Johnson | 4 | $157 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $150 |
| Seagen Inc. | 7 | $135 |
| Novartis | 4 | $103 |
| AbbVie | 4 | $95 |
| GSK | 3 | $85 |
| Astellas Pharma US Inc | 4 | $73 |
| Taiho Oncology, Inc. | 3 | $70 |
| Merck | 3 | $59 |
| EUSA Pharma (US) LLC | 3 | $52 |
| Sanofi | 3 | $52 |
| Boehringer Ingelheim | 2 | $50 |
| Lundbeck LLC | 2 | $49 |
| Incyte Corporation | 2 | $41 |
| Gilead | 1 | $30 |
| Tersera Therapeutics LLC | 1 | $29 |
| Daiichi Sankyo Inc. | 1 | $26 |
| E.r. Squibb & Sons, L.L.C. | 1 | $24 |
| Myovant Sciences Inc. | 1 | $24 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
| Pfizer | 1 | $21 |
| Array Biopharma Inc | 1 | $20 |
| Clovis Oncology, Inc. | 1 | $20 |
| Blueprint Medicines Corporation | 1 | $20 |
| Alnylam Pharmaceuticals Inc. | 1 | $20 |
| Pharmacosmos Therapeutics Inc. | 1 | $20 |
| Bayer | 1 | $19 |
| Sobi, Inc | 1 | $19 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
| Beigene USA, Inc. | 1 | $16 |
| EMD Serono, Inc. | 1 | $15 |
| Karyopharm Therapeutics Inc. | 1 | $14 |
| Organon | 1 | $14 |
| Exelixis Inc. | 1 | $14 |
| Eisai Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UPLIZNA$119
How this compares
$2,152 in reported general payments places this provider in the 90th percentile of 1,843 general practice providers in Maryland.
Other general practice in Baldwin
- Nancy WardBaltimore$282K
- Craig WashingtonFrederick$271K
- Paul NiesenGaithersburg$257K
- Kevin FriedmanBethesda$148K
- Edward SwansonBaltimore$123K
- Gregori KurtzmanSilver Spring$112K
- Russell MorrowWaldorf$86K
- Thomas YoonGaithersburg$73K
- Eric RabovskyCrownsville$35K
- Brittany BergeronTowson$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.